The company's proprietary technology is designed and engineered to produce nucleotide sugars more efficiently than ever before. They are also working on engineering biocatalysts to produce human milk oligosaccharides and tailor the glycosylation of therapeutic proteins. Eversyn is run, founded and supported by a team of current and former Max Planck scientists and business professionals.